1850 related articles for article (PubMed ID: 25548491)
1. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
[TBL] [Abstract][Full Text] [Related]
2. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
[TBL] [Abstract][Full Text] [Related]
3. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome and its components as predictors of nonalcoholic fatty liver disease in a northern urban Han Chinese population: a prospective cohort study.
Zhang T; Zhang C; Zhang Y; Tang F; Li H; Zhang Q; Lin H; Wu S; Liu Y; Xue F
Atherosclerosis; 2015 May; 240(1):144-8. PubMed ID: 25785362
[TBL] [Abstract][Full Text] [Related]
5. Lean non-alcoholic fatty liver disease and associated metabolic disturbance: A Saudi Arabian cross-sectional study.
Khayyat YM
Physiol Rep; 2021 Jul; 9(14):e14949. PubMed ID: 34278728
[TBL] [Abstract][Full Text] [Related]
6. [The relationship between non-alcoholic fatty liver disease and metabolic syndrome in patients with latent autoimmune diabetes in adults].
Yu TP; Zhao CC; Chen MY; Lu JX; Li LX; Jia WP
Zhonghua Yi Xue Za Zhi; 2018 Aug; 98(30):2398-2402. PubMed ID: 30138983
[No Abstract] [Full Text] [Related]
7. Association between the lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes in a healthy population of Northwest China: a retrospective cohort study with a 2-year follow-up period.
Li N; Xang W; Wu S; Li D; Chang M; Xie C; Zhang MY; Tan H
Front Endocrinol (Lausanne); 2023; 14():1173757. PubMed ID: 37435491
[TBL] [Abstract][Full Text] [Related]
8. The albumin-to-alkaline phosphatase ratio as an independent predictor of future non-alcoholic fatty liver disease in a 5-year longitudinal cohort study of a non-obese Chinese population.
Sheng G; Peng N; Hu C; Zhong L; Zhong M; Zou Y
Lipids Health Dis; 2021 May; 20(1):50. PubMed ID: 33993872
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal.
Pardhe BD; Shakya S; Bhetwal A; Mathias J; Khanal PR; Pandit R; Shakya J; Joshi HO; Marahatta SB
BMC Gastroenterol; 2018 Jul; 18(1):109. PubMed ID: 29980170
[TBL] [Abstract][Full Text] [Related]
10. Clinical Characteristics and Metabolic Profiles of Non-Alcoholic Fatty Liver Disease (NAFLD) in Lean Patients and Their Comparison with Obese and Overweight NAFLD.
Chakrabarty M; Jha AN; Sharma DJ
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443531
[TBL] [Abstract][Full Text] [Related]
11. Risk factors and metabolic abnormality of patients with non-alcoholic fatty liver disease: Either non-obese or obese Chinese population.
Lee SW; Lee TY; Yang SS; Tung CF; Yeh HZ; Chang CS
Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):45-48. PubMed ID: 29428103
[TBL] [Abstract][Full Text] [Related]
12. Both WHR and FLI as Better Algorithms for Both Lean and Overweight/Obese NAFLD in a Chinese Population.
Li C; Guo P; Zhang R; Zhang M; Li Y; Huang M; Ji X; Jiang Y; Wang C; Li R; Feng R;
J Clin Gastroenterol; 2019 Jul; 53(6):e253-e260. PubMed ID: 30045169
[TBL] [Abstract][Full Text] [Related]
13. Non-obese or lean non-alcoholic fatty liver disease was associated with increased risk of cancer in patients with type 2 diabetes mellitus.
Chen N; Zhou J; Wang K; Li X; Li Z
BMJ Open Diabetes Res Care; 2023 Feb; 11(1):. PubMed ID: 36792168
[TBL] [Abstract][Full Text] [Related]
14. Non-alcoholic fatty liver disease's prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the Chinese.
Hou XH; Zhu YX; Lu HJ; Chen HF; Li Q; Jiang S; Xiang KS; Jia WP
J Gastroenterol Hepatol; 2011 Apr; 26(4):722-30. PubMed ID: 21418302
[TBL] [Abstract][Full Text] [Related]
15. Triglyceride glucose index, pediatric NAFLD fibrosis index, and triglyceride-to-high-density lipoprotein cholesterol ratio are the most predictive markers of the metabolically unhealthy phenotype in overweight/obese adolescent boys.
Furdela V; Pavlyshyn H; Shulhai AM; Kozak K; Furdela M
Front Endocrinol (Lausanne); 2023; 14():1124019. PubMed ID: 37234798
[TBL] [Abstract][Full Text] [Related]
16. Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults.
Kwon YM; Oh SW; Hwang SS; Lee C; Kwon H; Chung GE
Am J Gastroenterol; 2012 Dec; 107(12):1852-8. PubMed ID: 23032980
[TBL] [Abstract][Full Text] [Related]
17. Different predictors of steatosis and fibrosis severity among lean, overweight and obese patients with nonalcoholic fatty liver disease.
Shao C; Ye J; Li F; Feng S; Wang W; Zhong B
Dig Liver Dis; 2019 Oct; 51(10):1392-1399. PubMed ID: 30928418
[TBL] [Abstract][Full Text] [Related]
18. Younger age of escalation of cardiovascular risk factors in Asian Indian subjects.
Gupta R; Misra A; Vikram NK; Kondal D; Gupta SS; Agrawal A; Pandey RM
BMC Cardiovasc Disord; 2009 Jul; 9():28. PubMed ID: 19575817
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease.
Zeng J; Yang RX; Sun C; Pan Q; Zhang RN; Chen GY; Hu Y; Fan JG
World J Gastroenterol; 2020 Apr; 26(15):1792-1804. PubMed ID: 32351294
[TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians.
Thakur ML; Sharma S; Kumar A; Bhatt SP; Luthra K; Guleria R; Pandey RM; Vikram NK
Atherosclerosis; 2012 Aug; 223(2):507-11. PubMed ID: 22748277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
